@endoindia · 1K subscribers
One Stop Destination for Endocrinology and Diabetes Updates relevant to India. Inviting Interested Individuals to Join.
The short link opens the channel straight in the Telegram app — not in a browser tab.
tg.me/go/endoindiaIs this your channel? Add @tgme as admin — and see how many people click your links. Get the stats →
Channel created June 15, 2021per Telegram
We have been tracking it since August 13, 2026
In all that time the channel has changed neither its name, nor its @username, nor its avatar.
We show only what we have seen ourselves.
Weight-loss drugs show signs of slowing biological aging, say drugmakers – MIT Technology Review https://www.technologyreview.com/2026/10/06/1145836/weight-loss-drugs-glp1-lilly-novo-aging-clocks/amp/
https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-orforglipron-172-mg-showed-greater-weight-loss
Wegovy helps free 40% of kids from obesity in phase 3 trial https://www.fiercepharma.com/pharma/novo-nordisks-wegovy-helps-free-40-kids-obesity-phase-3-trial
Novo Nordisk (NVO)’s Pediatric Obesity Opportunity Faces a Bigger Test https://share.google/nXPUBXvHCw63zzZ2F
Novo Nordisk says Wegovy approved in China for liver disease MASH https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-says-wegovy-approved-china-liver-disease-mash-2026-09-10/
